ȸ¿ø°¡ÀÔ | ¿¬¶ôó | »çÀÌÆ®¸Ê | English

      È¸»ç¼Ò°³ | ¸®Æ÷Æ® | Ä¿½ºÅÒ ¸®¼­Ä¡ | °í°´Áö¿ø


·Î±×ÀÎ

Ä«Å×°í¸®

À¯/¹«¼±Åë½Å

Àü±â/ÀüÀÚ

µðÁöÅбâ±â/¹Ìµð¾î/¹æ¼Û

Information Technology

¿¡³ÊÁö

»ý¸í°øÇÐ

È­ÇÐ/½Å¼ÒÀç

ÀÚµ¿Â÷

ȯ°æ

ÀϹݼҺñÀç

¸¶ÄÉÆÃ/±¤°í

±ÝÀ¶

°Ç¼³

±³Åë/¿î¼Û

¼ÒºñÀÚÁ¶»ç

¹æÀ§/Ç×°ø/¿ìÁÖ

½ÄÀ½·á

Áß°ø¾÷

±³À°

±â°è

¹«¿ª

½ºÆ÷Ã÷/·¹Àú

ÇØ¿î/Á¶¼±

ÆмÇ

Á¤ºÎ/Á¤Ã¥

°ø¿¹/±Í±Ý¼Ó

ÄÄÆÛ´Ï ÇÁ·ÎÆÄÀÏ

±âŸ»ê¾÷

 
ÇöÀçÀ§Ä¡ : HOME > ¸®Æ÷Æ® > »ý¸í°øÇÐ > Áø´Ü
US Newborn Screening Market Outlook 2020
¹ßÇà»ç RNCOS

¹ßÇàÀÏ 2016-03-10
ºÐ·® 40 pages
¼­ºñ½ºÇüÅ Report
ÆǸŰ¡°Ý

ÀμâÇϱâ

Executive Summary

The US Newborn Screening market is set to witness several developments in near future. In the new report entitled, ¡°US Newborn Screening Market Outlook 2020¡± the market has been separately studied under tests used for screening, and technologies supporting the diagnosis.

93% of the newborns are screened for various disorders under the newborn screening test in the US. The government is taking various measures to improve the quality and efficiency of these tests. Furthermore, the governments of various states are also engaged in expanding the panel of the tests.

Blood spot test is the most widely performed newborn screening test, followed by hearing screening and Critical Congenital Heart Disease (CCHD) Newborn Screening respectively. The screening technologies used for these tests include tandem mass spectrometry, immunoassays, pulse oximetry, DNA assays and electrophoresis. Immunoassay is the most extensively used technology for newborn screening. The large share of this technology is attributed to the fact that it is a part of primary screening tests for the newborn. Hence, these tests would always witness higher demand.

The report covers developments in the market occurring over the last two years, drivers and challenges controlling the market, and competitive landscape showing prominent players. Factors such as government support through funds, growing awareness, technological advancements and surging genetic disorders are fuelling the growth. On the other hand, lack of uniform regulatory policies in the country and delays in hospital administration are major hurdles of the market.

The study includes prudent analysis of the market size (tests and technologies) for 2014, and forecast till 2020. At the competitive forefront, research has been done at each player including their financials, key products, developments and SWOT analysis. In brief, study presented in the report is likely to generate interest among the potential investors.


ȸ»ç¼Ò°³ | °³ÀÎÁ¤º¸º¸È£Á¤Ã¥ | ÀÌ¿ë¾à°ü | ¹è¼Û/°áÁ¦¾È³» | ÀÌ¿ë¾È³»

¼­¿ï½Ã °­³²±¸ ³íÇöµ¿ 210-1 »ï¿øºôµù | ȸ»ç¸í : (ÁÖ)¿¤¾Ø¿¡Ä¡
´ëÇ¥ÀüÈ­ : 02-554-0001 / Æѽº : 02-3444-5501 / À̸ÞÀÏ : sales@landh.co.kr
Copyright ¨Ï 2008 LNH, Inc. All rights reserved.